Why the study?
Does ramipril alter hemodynamic parameters in patients with mild to moderate aortic stenosis and preserved left ventricular function?
Does ramipril alter hemodynamic parameters in patients with mild to moderate aortic stenosis and preserved left ventricular function?
Short-term treatment with ramipril up to 7.5 mg twice daily is well tolerated and does not significantly alter hemodynamics in patients with mild to moderate aortic stenosis and preserved left ventricular function, challenging the presumed contraindication.
Answers are grounded in this paper and cite their sources.
Ramipril was not associated with hemodynamic changes in mild-moderate AS; leaves open long-term safety and requires randomized confirmation.
Background Angiotensin-converting enzyme (ACE) inhibitor use is presumed to be contraindicated in patients with aortic stenosis (AS). We determined the hemodynamic effects of ACE inhibitors in patients with mild to moderate aortic stenosis (AS) and preserved left ventricular function. Methods Thirteen elderly patients (mean [SD] age = 65 [17] years), with mild to moderate AS (aortic jet velocity 2.5–4.0 m/s), normal left ventricular and renal function, and no clinical coronary artery disease, were enrolled in a single-center, open-label trial comparing the hemodynamic effects at baseline and following titration of ramipril to a maximum dose of 7.5 mg twice daily. Patients were identified from echocardiography laboratory logs. Despite a presumed contraindication to ACE inhibitor use in AS patients, 30% (71 of 235) of patients otherwise meeting inclusion or exclusion criteria were excluded owing to current ACE inhibitor use. Patients were monitored with weekly clinic visits, biweekly laboratory tests, and monthly echocardiograms. Results There were no significant changes from baseline to week 8 in echocardiographic parameters, including mean (SD) aortic jet velocity [2.9 (0.4) vs 2.9 (0.4) m/s], calculated aortic transvalvular gradient [18 (6) vs 18 (6) mm Hg], or cardiac output [5.5 (1.2) vs 6.0 (2.1) L/min], or significant changes in blood pressure or heart rate. Early discontinuations were for asymptomatic low blood pressure (one patient) or a reversible creatinine increase of 0.3 mg/dL (one patient). Conclusions Short-term treatment with up to 7.5 mg twice daily of ramipril was well tolerated in patients with mild to moderate AS and preserved left ventricular function. A surprisingly high proportion of patients with documented AS were already receiving ACE inhibitors.
No takes yet. Share an insight, caveat, or question.
O’Brien et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: